p53 alterations in atypical alveolar hyperplasia of the human lung

Human Pathology

Volumn 29, Issue 8, 1998, Pages 801-808

  Slebos, Robbert J C ^b   Baas, Inge O ^b   Clement, Marjon J ^b   Offerhaus, G Johan A ^b   Askin, Fredric B ^b   Hruban, Ralph H ^b   Westra, William H ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NONE

Author keywords

Atypical adenomatous hyperplasia; Atypical alveolar hyperplasia; Early glandular neoplasm; Lung; Lung adenocarcinoma; Lung cancer; P53

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER GRADING; CLINICAL ARTICLE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS; LUNG CANCER; LUNG CARCINOGENESIS; MALIGNANT TRANSFORMATION; MISSENSE MUTATION; PROTEIN DETERMINATION;

EID: 0031879860     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90448-8     Document Type: Article

References (34)

1. Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532, 1988
2. Westra WH, Baas IO, Hruban RH, et al: K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res 56:2224-2228, 1996
3. Rao SK, Fraire AE: Alveolar cell hyperplasia in association with adenocarcinoma of lung. Mod Pathol 8:165-169, 1995
4. Levine AJ: The p53 tumor-suppressor gene. N Engl J Med 326:1350-1352, 1992
5. Kern SE: p53: Tumor suppression through control of the cell cycle. Gastroenterology 106:1708-1711, 1994
6. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990
7. Cho KR, Vogelstein B: Genetic alterations in the adenoma carcinoma sequence. Cancer 70:1727-1731, 1992
8. Baker SJ, Preisinger AC, Jessup JM, et al: p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50:7717-7722, 1990
9. Bennett WP, Colby TV, Travis WD, et al: p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res 53:4817-4822, 1993
10. Hirano T, Franzen B, Kato H, et al: Genesis of squamous cell lung carcinoma: Sequential changes of proliferation, DNA ploidy, and p53 expression. Am J Pathol 144;296-302, 1994
11. Nuorva K, Soini Y, Kamel D, et al: Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. Am J Pathol 142:725-732, 1993
12. Sozzi G, Miozzo M, Donghi R, et al: Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 52:6079-6092, 1992
13. Li ZH, Zheng J, Weiss LM, et al: c-K-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am J Pathol 144:303-309, 1994
14. Kerr KM, Carey FA, King G, et al: Atypical alveolar hyperplasia: Relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression. J Pathol 174:249-256, 1994
15. Kitamura H, Kameda Y, Nakamura N, et al: Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma: Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. Am J Surg Pathol 20:553-562, 1996
16. Kitamura H, Kameda Y, Nakamura N, et al: Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma. Am J Pathol 146:876-887, 1995
17. Nakanishi K: Alveolar epithelial hyperplasia and adenocarcinoma of the lung. Arch Pathol Lab Med 114:363-368, 1990
18. Baas IO, Mulder JWR, Offerhaus GJA, et al: An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172:5-12, 1994
19. Iggo R, Gatter K, Bartek J, et al: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335:675-679, 1990
20. Cunningham J, Lust JA, Schaid DJ, et al: Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res 52:1974-1980, 1992
21. Cripps KJ, Purdie CA, Carder PJ, et al: A study of stabilization of p53 protein versus point mutation in colorectal carcinoma. Oncogene 9:2739-2743, 1994
22. Slebos RJC, Baas IO, Clement MJ, et al: Clinical and pathological associations with p53 tumour suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma. Br J Cancer 74:165-171, 1996
23. Hollstein M, Sidransky D, Vogelstein B, et al: p53 mutations in human cancers. Science 253:49-53, 1991
24. Peterson GM: Epidemiology, screening, and prevention of lung cancer. Curr Opin Oncol 6:156-161, 1994
25. Hammar SP: Common neoplasms, in Dail DH, Hammar SP (eds): Pulmonary Pathology. New York, NY, Springer-Verlag; 1994, pp 1123-1278
26. Miller RR, Nelems B, Evans KG, et al: Glandular neoplasia of the lung: A proposed analogy to colonic tumors. Cancer 61:1009-1014, 1988
27. Westra WH, Offerhaus GJA, Goodman SN, et al: Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking. Am J Surg Pathol 17:213-220, 1993
28. Nakayama H, Noguchi M, Tsuchiya R, et al: Clonal growth of atypical adenomatous hyperplasia of the lung: Cytofluorometric analysis of nuclear DNA content. Mod Pathol 3:314-320, 1990
29. Solomon MD, Greenberg SD, Spjut HJ: Morphology of bronchial epithelium adjacent to adenocarcinoma of the lung. Mod Pathol 3:684-687, 1990
30. Ohshima S, Shimizu Y, Takahama M: Detection of c-Ki-ras gene mutation in paraffin sections of adenocarcinoma and atypical bronchioloalveolar cell hyperplasia of human lung. Virchows Arch 424:129-134, 1994
31. Cagle PT, Fraire AE, Greenberg SD, et al: Potential utility of p53 immunopositivity in differentiation of adenocarcinomas from reactive epithelial atypias of the lung. HUM PATHOL 27:1198-1203, 1996
32. Hall PA, Lane DP: p53 in tumor pathology: Can we trust immunohistochemistry? Revisited! J Pathol 172:1-4, 1994
33. Maltzman W, Czyzyk L: UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 4:1689-1694, 1984
34. Mao L, Hruban RH, Boyle JO, et al: Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 54:1634-1637, 1994